To lay bare the benefits and harms about medicines, researchers often need to get into the nitty-gritty details found in the data from the participants in clinical trials. Summary results often just don’t cut it. We’re highlighting some of the research that demonstrates the benefits of these detailed analyses to make the case for providing researchers with greater access to trial data.
Please share these stories on Facebook and Twitter (#AllTrials).
A review of the individual patient data from 12 clinical trials showed that chemotherapy provided a small but significant increase in survival among people with the most common type of brain tumour.
Malignant gliomas are a deadly cancer of the brain and spine, most common in childhood and at age 50-60 years. Treatment generally involves radiotherapy […]
Following an analysis of individual patient data (IPD), doctors were able to offer a less painful surgery to treat the most common type of hernia.
When people age, muscles become weaker and the intestines can sometimes push through weak spots causing a hernia. These can be painful and in some cases require surgery to treat. Doctors […]
To lay bare the benefits and harms about medicines, researchers often need to get into the nitty-gritty details found in the data from the participants in clinical trials. Summary results often just don’t cut it. This week, AllTrials will be highlighting some of the research that demonstrates the benefits of these detailed analyses to make […]